NCT02533362View on ClinicalTrials.gov

ANF-Rho in the Treatment of Chronic Neutropenia

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Neutropenia, Severe Chronic
Interventions
DRUG

ANF-Rho

Pegylated version of recombinant human granulocyte-colony stimulating factor (G-CSF)

Sponsors
All Listed Sponsors
lead

Prolong Pharmaceuticals

INDUSTRY